ReviewExploration of targeted anti-tumor therapy2023
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline
Sabah Alaklabi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.